November 28, 2014 4:50 PM ET

Pharmaceuticals

Company Overview of Breckenridge Pharmaceutical, Inc.

Company Overview

Breckenridge Pharmaceutical, Inc. researches, develops, and markets generic prescription products in various therapeutic categories. The company markets its products in various dosage forms, including tablets, capsules, soft gel capsules, liquids, suspensions, and powders. It also provides various medical foods for the dietary management of patients with therapeutic or chronic medical needs; and prenatal and dietary supplements. In addition, the company handles various aspects of business operations, including procurement, purchasing, inventory management, warehousing, distribution, transportation, and customer service support. It serves chains, managed care customers, wholesalers, and distr...

6111 Broken Sound Parkway NW

Suite 170

Boca Raton, FL 33487

United States

Founded in 1983

Phone:

561-443-3314

Fax:

561-989-9747

Key Executives for Breckenridge Pharmaceutical, Inc.

President
Director of Operations
Senior Vice President of Sales for New Jersey Office
Executive Vice President of CT Office
Vice President of Finance for Ct Office
Compensation as of Fiscal Year 2014.

Breckenridge Pharmaceutical, Inc. Key Developments

Breckenridge Pharmaceutical Signs Multi-Product Generic Agreement with Pharmaceutics International, Inc

Breckenridge Pharmaceutical, Inc. announced that it has entered into a multi-product ANDA agreement with Pii (Pharmaceutics International, Inc.) under which Breckenridge and Pii expect to develop and commercialize several new ANDA's. Under the terms of the agreement, Pii will develop, manufacture and supply the products, and Breckenridge will market and distribute the products under its own label. The drugs, comprised of four unique dosage forms, and have combined U.S. market sales in excess of $1.6 billion, in the 12-month period ending September 30, 2014. The multi-product agreement contemplates the submission of multiple ANDA's with Paragraph IV certifications.

Breckenridge Announces Approval of Quetiapine Fumarate Tablets

Breckenridge Pharmaceutical, Inc. announced the approval of Quetiapine Fumarate Tablets. Quetiapine Fumarate Tablets are AB rated to Seroquel a $395 million generic drug marketed by the AstraZeneca group of companies. Seroquel(R) is an atypical antipsychotic indicated for the treatment of Schizophrenia and Bipolar disorders. The product launch plans are still being finalized. Breckenridge's Quetiapine Fumarate Tablets are supplied under a deal with Medikl Ltd. Cyprus and are manufactured and supplied by Alembic Pharmaceutical's, the ANDA holder. The product will be supplied in 25, 50, 100, 200, 300 AND 400mg strengths.

Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg

Breckenridge Pharmaceutical, Inc. announced the immediate launch of Mefenamic Acid 250mg Capsules. The U.S. Food and Drug Administration previously granted final approval for the Abbreviated New Drug Application (ANDA) for this product. This product is one of five approved Breckenridge ANDA products secured from the September 2013 acquisition of certain Cypress Pharmaceutical, Inc. product assets. Breckenridge's Mefenamic Acid Capsules are AB rated to Ponstel(R) a generic drug marketed by Shionogi Pharma, Inc., a $10.3 million generic based on August 2014 IMS Health sales data. Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the relief of mild to moderate pain in patients greater than or equal to 14 years of age, when therapy will not exceed one week (7 days). It is also indicated for the treatment of primary dysmenorrhea.

Similar Private Companies By Industry

Company Name Region
Dey, Inc. United States
Sino Lion (USA), Ltd. United States
PTS Intermediate Holdings LLC United States
Caraloe Inc. United States
Kyowa Hakko Kogyo Pharma, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
February 6, 2014
Cypress Pharmaceutical, Inc., Portfolio Of 25 Generics
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Breckenridge Pharmaceutical, Inc., please visit www.bpirx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.